Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
In vascular disease states such as atherosclerosis and diabetes, endothelial nitric oxide (NO) bioactivity is reduced and oxidative stress is increased, resulting in endothelial dysfunction. Recent studies suggest that changes in the activity and regulation of endothelial NO synthase by its cofactor...
Κύριος συγγραφέας: | Channon, K |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2004
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.
ανά: Alp, N, κ.ά.
Έκδοση: (2004) -
Regulation of endothelial nitric oxide synthase (eNOS) by tetrahydrobiopterin in vascular disease
ανά: Alp, N, κ.ά.
Έκδοση: (2004) -
Tetrahydrobiopterin and nitric oxide synthase recouplers
ανά: Channon, KM
Έκδοση: (2020) -
Prevention of hypoxia-induced pulmonary hypertension and vascular remodelling by targeting endothelial tetrahydrobiopterin-dependent nitric oxide synthase regulation
ανά: Khoo, J, κ.ά.
Έκδοση: (2005) -
Endothelial tetrahydrobiopterin deficiency accelerates atherosclerotic progression by nitric oxide synthase uncoupling
ανά: Khoo, J, κ.ά.
Έκδοση: (2005)